Triple Moving Average Crossover
Previous Close | 0.8469 |
Open | 0.8356 |
Bid | 0.8777 x 800 |
Ask | 0.8779 x 1300 |
Day's Range | 0.8116 - 0.8900 |
52 Week Range | 0.7080 - 3.5500 |
Volume | |
Avg. Volume | 6,678,396 |
Market Cap | 420.392M |
Beta (5Y Monthly) | 1.99 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.6200 |
Earnings Date | Aug 07, 2023 - Aug 11, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 1.55 |
Clover Health Investments, Corp. (NASDAQ:CLOV) Q1 2023 Earnings Call Transcript May 9, 2023 Operator: Ladies and gentlemen, good afternoon, and welcome to the Clover Health First Quarter 2023 Earnings Conference Call. As a reminder, today’s call is being recorded. I would now like to turn the call over to Ryan Schmidt, Investor Relations for Clover […]
Insurance revenue grew by 14% over Q1’22 Insurance and Non-Insurance MCR improved to 86.6% and 96.1%, respectively Improved 2023 guidance includes Insurance MCR of 87% - 89%, Insurance revenue of $1.18 billion - $1.23 billion, and Adjusted EBITDA of ($125) million - ($175) million FRANKLIN, Tenn., May 09, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) ("Clover," "Clover Health" or the "Company"), a physician enablement company committed to bringing access to great healt
FRANKLIN, Tenn., May 04, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to improving health equity for seniors, today announced that its CFO, Scott J. Leffler, will present at the Bank of America 2023 Healthcare Conference on Thursday, May 11, 2023, at 1:40 p.m. Eastern Time. A live webcast of the presentation will be accessible from Clover Health's investor relations website at https
FRANKLIN, Tenn., April 24, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, today announced that the Company has reached an agreement to resolve the securities class action captioned Bond v. Clover Health Investments, Corp. et al., Case No. 3:21-CV-00096 (M.D. Tenn.) (the “securities class action”), which was filed in the w
Net annualized savings from initiatives expected to be approximately $30 million beginning in 2024 FRANKLIN, Tenn., April 17, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover” or “Clover Health” or “the company”), today announced business transformation initiatives to accelerate the company’s path to profitability, including an agreement to move its core plan operations to UST HealthProof’s integrated technology platform and additional corporate restructuring act
FRANKLIN, Tenn., April 11, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, today announced that it will report first quarter 2023 financial results after market close on Tuesday, May 9, 2023. On that day management will host a conference call and webcast at 5:00 p.m. Eastern Time to discuss the Company’s business and finan
FRANKLIN, Tenn., March 07, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to improving health equity for seniors, today announced that its CFO, Scott J. Leffler, will present at Barclays 2023 Global Healthcare Conference on Tuesday, March 14, 2023, at 4:05 p.m. Eastern Time. A live webcast of the presentation will be accessible from Clover Health's investor relations website at https:
Q4 2022 Insurance MCR of 92.4% and FY 2022 Insurance MCR of 91.8% 2023 guidance Insurance MCR range of 89% - 91%, and Non-Insurance MCR range of 98% to 100% Strong liquidity expected to meet 2023 operating requirements FRANKLIN, Tenn., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) ("Clover," "Clover Health" or the "Company"), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, today reported financial result
FRANKLIN, Tenn., Feb. 22, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to improving health equity for seniors, today announced that its CEO, Andrew Toy, will present at Citi's 2023 Healthcare Conference on Wednesday, March 1, 2023, at 8:45 a.m. Eastern Time. A live webcast of the presentation will be accessible from Clover Health's investor relations website at https://investors.clo
FRANKLIN, Tenn., Jan. 30, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, today announced that it will report fourth quarter and full year 2022 financial results before market open on Tuesday, February 28, 2023. On that day management will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss the Company’
FRANKLIN, Tenn., Jan. 10, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, today provides a business update and announces partial guidance for full-year 2023. “2023 will be a pivotal year for Clover Health and I believe we will prove out the strength of our approach to managing care for Medicare beneficiaries. It’s an excit
FRANKLIN, Tenn., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to improving health equity for seniors, today announced that its CEO, Andrew Toy, will present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023, at 4:30 p.m. Eastern Time. A live webcast of the presentation will be accessible from Clover Health's investor relations website at ht
FRANKLIN, Tenn., Dec. 13, 2022 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to improving health equity for seniors, today issued December Investor Frequently Asked Questions on its investor relations website at https://investors.cloverhealth.com/investor-resources/FAQs. Clover may continue to provide updates to Investor Frequently Asked Questions on its investor website. Forward-Looking
FRANKLIN, Tenn., Nov. 30, 2022 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to improving health equity for seniors, today announced the appointment of Anna Loengard, M.D. to the Company’s Board of Directors. Dr. Loengard is a highly accomplished physician executive with significant experience in both geriatric medicine and value based care models. She most recently served as Chief Medica
Third quarter Insurance MCR of 86.3% and year-to-date Insurance MCR of 91.7% demonstrate positive momentum The Company updates 2022 full year guidance to include improved 2022 Insurance MCR range of 93% to 94% Clover intends to continue to grow Insurance business at above-market rates in 2023 but will moderate growth to prioritize profitability Company outlines strategic reduction in number of ACO REACH participating physicians in 2023; targeting Non-Insurance MCR below 100% The Company reports
FRANKLIN, Tenn., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to improving health equity for seniors, today announced that its CEO, Vivek Garipalli, will present at the Credit Suisse 31st Annual Healthcare Conference on Thursday, November 10, 2022, at 12:10 p.m. Eastern Time. A live webcast of the presentation will be accessible from Clover Health's investor relations websi
FRANKLIN, Tenn., Oct. 11, 2022 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”) today announced that for the 2021 measurement year, the Centers for Medicare and Medicaid Services (“CMS”) has rated its PPO Medicare Advantage (“MA”) plan at 3.5 stars and increased the rating of its HMO MA plan from 3 stars to 3.5 stars on the Medicare Star Ratings. Currently, over 90% of Clover’s MA membership is served through its PPO plan. “Our goal
FRANKLIN, Tenn., Oct. 10, 2022 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to improving health equity for seniors, today announced that it will report third quarter 2022 financial results after market close on Monday, November 7, 2022. On that day management will host a conference call and webcast at 5:00 p.m. Eastern Time to discuss the Company’s business and financial results. Third Q
Going into 2023, Clover continues to focus on providing high-value, low-cost, wide-network Medicare Advantage plansIn addition, company launches LiveHealthy Rewards to encourage members to complete activities directly aimed at improving their health and wellness FRANKLIN, Tenn., Oct. 06, 2022 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover” or “Clover Health”), a physician enablement company committed to improving health equity for seniors, today debuted its 2023 Med
FRANKLIN, Tenn., Aug. 31, 2022 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to improving health equity for seniors, today announced that its CEO, Vivek Garipalli, will present at the 2022 Wells Fargo Healthcare Conference on Wednesday, September 7, 2022, at 9:10 a.m. Eastern Time. A live webcast of the presentation will be accessible from Clover Health's investor relations website at htt
Drug pricing negotiations for Medicare are a long way from reality, but CMS is already looking for the help it will need.
Second quarter total revenue was $846.7 million compared to $412.5 million in second quarter 2021 Lives under Clover Management grew to ~255,000 from ~129,000 year-over-year Second quarter Insurance (Medicare Advantage) Medical Care Ratio ("MCR") of 92.1% shows significant improvement year-over-year FRANKLIN, Tenn., Aug. 08, 2022 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) ("Clover," "Clover Health" or the "Company"), a physician enablement company committed to improving
Vivek Garipalli to transition the role of CEO to Co-Founder and President Andrew Toy effective January 1, 2023; Mr. Garipalli to continue with Clover as Executive Chairperson moving forwardFRANKLIN, Tenn., Aug. 08, 2022 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover” or “Clover Health”) today announced that Vivek Garipalli, its founder and current Chief Executive Officer (“CEO”) and Chairperson, will transition his role of CEO to Co-Founder and President Andrew Toy,
FRANKLIN, Tenn., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to improving health equity for seniors, today announced that its CEO, Vivek Garipalli, will present at the Canaccord Genuity 42nd Annual Growth Conference on Wednesday, August 10, 2022, at 2:00 p.m. Eastern Time. A live webcast of the presentation will be accessible from Clover Health's investor relations website
FRANKLIN, Tenn., July 26, 2022 (GLOBE NEWSWIRE) -- On July 25, 2022, Scott J. Leffler joined Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover” or the “Company”) as its Chief Financial Officer (CFO). Mr. Leffler’s appointment was previously announced in May 2022. In connection with his appointment, Mr. Leffler was issued an inducement restricted stock unit award approved by the Talent and Compensation Committee of the Company’s Board of Directors. The majority of the restricted stock unit